Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ASML Holding N.V. Interim / Quarterly Report 2009

Oct 14, 2009

3813_iss_2009-10-14_aefedf5d-fd40-49cd-a843-b8f0204577ad.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Three months ended, Nine months ended,
Sep 28, 2008 Sep 27, 2009 Sep 28, 2008 Sep 27, 2009
(in thousands EUR, except per share data)
Net system sales 590,723 458,691 2,136,296 743,050
Net service and field option sales 105,770 96,581 323,562 272,447
Total net sales 696,493 555,272 2,459,858 1,015,497
Cost of sales 431,062 364,013 1,483,334 777,438
Gross profit on sales 265,431 191,259 976,524 238,059
Research and development costs, net of credits 130,157 115,166 388,657 351,371
Selling, general and administrative costs 51,933 37,537 165,628 119,510
Income (loss) from operations 83,341 38,556 422,239 (232,822)
Interest income (expense) 7,059 (2,383) 17,633 (3,652)
Income (loss) from operations before income taxes 90,400 36,173 439,872 (236,474)
(Provision for) benefit from income taxes (17,106) (16,434) (29,478) 35,069
Net income (loss) 73,294 19,739 410,394 (201,405)
Basic net income (loss) per ordinary share 0.17 0.05 0.95 (0.47)
Diluted net income (loss) per ordinary share 2 0.17 0.05 0.94 (0.47)
Number of ordinary shares used in computing per share amounts (in thousands):
Basic 431,672 432,675 431,498 432,414
Diluted 2 434,491 434,975 434,859 432,414

ASML - Summary U.S. GAAP Consolidated Statements of Operations 1

ASML - Ratios and Other Data 1

Three months ended, Nine months ended,
Sep 28, 2008 Sep 27, 2009 Sep 28, 2008 Sep 27, 2009
Gross profit as a % of net sales 38.1 34.4 39.7 23.4
Income (loss) from operations as a % of net sales 12.0 6.9 17.2 (22.9)
Net income (loss) as a % of net sales 10.5 3.6 16.7 (19.8)
Shareholders' equity as a % of total assets 50.3 47.8 50.3 47.8
Income taxes as a % of income before income taxes (18.9) (45.4) (6.7) (14.8)
Sales of systems (in units) 37 24 126 45
ASP of systems sales (EUR million) 16.0 19.1 17.0 16.5
Value of backlog systems (EUR million) 1,028 1,353 1,028 1,353
Backlog systems (in units) 53 54 53 54
ASP of backlog systems (EUR million) 19.4 25.1 19.4 25.1
Value of booked systems (EUR million) 498 777 1,443 1,378
Net bookings (in units) 31 35 90 58
ASP of booked systems (EUR million) 16.1 22.2 16.0 23.8
Number of payroll employees in FTEs 6,907 6,529 6,907 6,529
Number of temporary employees in FTEs 1,610 917 1,610 917
Dec 31, 2008 Sep 27, 2009
(in thousands EUR)
ASSETS
Cash and cash equivalents 1,109,184 1,018,028
Accounts receivable, net 463,273 382,065
Finance receivables, net 6,225 21,151
Current tax assets 87,560 -
Inventories, net 999,150 882,369
Deferred tax assets 71,780 68,962
Other assets 236,077 224,240
Total current assets 2,973,249 2,596,815
Finance receivables, net 31,030 -
Deferred tax assets 148,133 193,466
Other assets 88,197 68,061
Goodwill 131,453 128,595
Other intangible assets, net 26,692 19,037
Property, plant and equipment, net 540,640 561,684
Total non-current assets 966,145 970,843
Total assets 3,939,394 3,567,658
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities 1,008,343 949,273
Long-term debt 647,050 660,191
Deferred and other tax liabilities 209,699 193,708
Provisions 15,495 13,506
Accrued liabilities and other liabilities 70,038 44,709
Total non-current liabilities 942,282 912,114
Total liabilities 1,950,625 1,861,387
Shareholders' equity 1,988,769 1,706,271
Total liabilities and shareholders' equity 3,939,394 3,567,658

ASML - Summary U.S. GAAP Consolidated Balance Sheets 1

Three months ended, Nine months ended,
Sep 28, 2008 Sep 27, 2009 Sep 28, 2008 Sep 27, 2009
(in thousands EUR)
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss) 73,294 19,739 410,394 (201,405)
Depreciation and amortization 28,625 39,302 84,102 108,838
Impairment 552 9,050 2,196 16,029
Loss on disposals of property, plant and equipment 1,413 859 3,827 3,037
Share-based payments 3,686 2,786 10,362 8,879
Allowance for doubtful debts (206) 672 (313) 1,836
Allowance for obsolete inventory 21,295 20,840 53,851 86,872
Deferred income taxes 2,421 (4,461) (31,447) (62,695)
Change in assets and liabilities (110,227) (154,188) (114,790) 117,324
Net cash provided by (used in) operating activities 20,853 (65,401) 418,182 78,715
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment (68,237) (13,511) (188,710) (97,267)
Proceeds from sale of property, plant and equipment - - - 6,877
Purchases of intangible assets (35) - (35) -
Net cash used in financing activities (68,272) (13,511) (188,745) (90,390)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid (394) - (107,841) (86,486)
Purchase of shares in conjunction with
share-based payment plans - - (87,605) -
Net proceeds from issuance of shares and stock options 1,439 4,183 4,966 4,714
Excess tax benefits (deficiencies) from stock options (1,946) 715 4,027 963
Net proceeds from other long-term debt - - - 32
Redemption and/or repayment of debt (1,280) (4) (1,280) (13)
Net cash provided by (used in) financing activities (2,181) 4,894 (187,733) (80,790)
Net cash flows (49,600) (74,018) 41,704 (92,465)
Effect of changes in exchange rates on cash 1,695 (614) (347) 1,309
Net increase (decrease) in cash & cash equivalents (47,905) (74,632) 41,357 (91,156)

ASML - Summary U.S. GAAP Consolidated Statements of Cash Flows 1

ASML - Quarterly Summary U.S. GAAP Consolidated Statements of Operations 1

Sep 28, Dec 31, Mar 29, Jun 28, Sep 27,
2008 2008 2009 2009 2009
(in millions EUR, except per share data)
Net system sales 590.7 380.5 101.1 183.3 458.7
Net service and field option sales 105.8 113.3 82.5 93.3 96.6
Total net sales 696.5 493.8 183.6 276.6 555.3
Cost of sales 431.1 454.8 171.2 242.2 364.0
Gross profit on sales 265.4 39.0 12.4 34.4 191.3
Research and development costs, net of credits 130.2 127.5 118.3 117.9 115.2
Selling, general and administrative costs 51.9 46.7 41.0 41.0 37.5
Income (loss) from operations 83.3 (135.2) (146.9) (124.5) 38.6
Interest income (expense) 7.1 5.0 (1.1) (0.2) (2.4)
Income (loss) from operations before income taxes 90.4 (130.2) (148.0) (124.7) 36.2
(Provision for) benefit from income taxes (17.1) 42.2 30.8 20.7 (16.5)
Net income (loss) 73.3 (88.0) (117.2) (104.0) 19.7
Basic net income (loss) per ordinary share 0.17 (0.20) (0.27) (0.24) 0.05
Diluted net income (loss) per ordinary share 2 0.17 (0.20) (0.27) (0.24) 0.05
Number of ordinary shares used in computing per share amounts (in thousands):
Basic 431,672 431,989 432,112 432,454 432,675
Diluted 2 434,491 431,989 432,112 432,454 434,975

Three months ended,

ASML - Quarterly Summary Ratios and other data 1

Three months ended,

Sep 28,
2008
Dec 31,
2008
Mar 29,
2009
Jun 28,
2009
Sep 27,
2009
Gross profit as a % of net sales 38.1 7.9 6.7 12.5 34.4
Income (loss) from operations as a % of net sales 12.0 (27.4) (80.0) (45.0) 6.9
Net income (loss) as a % of net sales 10.5 (17.8) (63.8) (37.6) 3.6
Shareholders' equity as a % of total assets 50.3 50.5 48.0 47.7 47.8
Income taxes as a % of income before income taxes (18.9) (32.4) (20.8) (16.6) (45.4)
Sales of systems (in units) 37 25 11 10 24
ASP of system sales (EUR million) 16.0 15.2 9.2 18.3 19.1
Value of backlog systems (EUR million) 1,028 755 853 1,064 1,353
Backlog systems (in units) 53 41 38 43 54
ASP of backlog systems (EUR million) 19.4 18.4 22.4 24.7 25.1
Value of booked systems (EUR million) 498 127 207 394 777
Net bookings (in units) 31 13 8 15 35
ASP of booked systems (EUR million) 16.1 9.8 25.8 26.3 22.2
Number of payroll employees in FTEs 6,907 6,930 6,715 6,597 6,529
Number of temporary employees in FTEs 1,610 1,329 959 868 917
Sep 28, Dec 31, Mar 29, Jun 28, Sep 27,
2008 2008 2009 2009 2009
(in millions EUR)
ASSETS
Cash and cash equivalents 1,313.0 1,109.2 1,151.0 1,092.7 1,018.0
Accounts receivable, net 536.1 463.3 291.6 213.5 382.1
Finance receivables, net 7.4 6.2 6.2 0.1 21.1
Current tax assets - 87.6 - - -
Inventories, net 1,134.0 999.1 936.8 926.1 882.4
Deferred tax assets 82.8 71.8 74.9 70.5 69.0
Other assets 261.4 236.1 240.6 220.2 224.2
Total current assets 3,334.7 2,973.3 2,701.1 2,523.1 2,596.8
Finance receivables, net 30.7 31.0 29.2 20.6 -
Deferred tax assets 139.4 148.1 173.2 198.9 193.5
Other assets 50.6 88.2 89.5 53.8 68.1
Goodwill 129.2 131.5 139.7 134.5 128.6
Other intangible assets, net 28.8 26.7 25.6 22.3 19.0
Property, plant and equipment, net 503.1 540.6 586.6 591.9 561.7
Total non-current assets 881.8 966.1 1,043.8 1,022.0 970.9
Total assets 4,216.5 3,939.4 3,744.9 3,545.1 3,567.7
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities 1,273.0 1,008.3 1,017.5 940.9 949.3
Long-term debt 596.7 647.1 661.4 651.9 660.2
Deferred and other tax liabilities 215.2 209.7 204.9 200.6 193.7
Provisions - 15.5 16.9 14.8 13.5
Accrued liabilities and other liabilities 8.8 70.0 48.2 45.6 44.7
Total non-current liabilities 820.7 942.3 931.4 912.9 912.1
Total liabilities 2,093.7 1,950.6 1,948.9 1,853.8 1,861.4
Shareholders' equity 2,122.8 1,988.8 1,796.0 1,691.3 1,706.3
Total liabilities and shareholders' equity 4,216.5 3,939.4 3,744.9 3,545.1 3,567.7

ASML - Summary U.S. GAAP Consolidated Balance Sheets 1

ASML - Summary U.S. GAAP Consolidated Statements of Cash Flows 1

Three months ended,

Sep 28, Dec 31, Mar 29, Jun 28, Sep 27,
2008 2008 2009 2009 2009
(in millions EUR)
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss) 73.3 (88.0) (117.2) (104.0) 19.7
Depreciation and amortization 28.6 35.1 37.9 31.6 39.3
Impairment 0.6 22.9 2.6 4.4 9.1
Loss (gain) on disposals of property, plant and equipment 1.4 0.4 2.6 (0.4) 0.9
Share-based payments 3.7 3.2 3.5 2.6 2.8
Allowance for doubtful debts (0.2) 0.5 - 1.2 0.7
Allowance for obsolete inventory 21.3 85.8 22.1 43.9 20.8
Deferred income taxes 2.4 (2.7) (27.0) (31.2) (4.5)
Change in assets and liabilities (110.2) (194.6) 157.7 113.8 (154.2)
Net cash provided by (used in) operating activities 20.9 (137.4) 82.2 61.9 (65.4)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment (68.3) (71.1) (43.9) (39.9) (13.5)
Proceeds from sale of property, plant and equipment - - 1.2 5.7 -
Net cash used in investing activities (68.3) (71.1) (42.7) (34.2) (13.5)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid (0.4) - - (86.5) -
Net proceeds from issuance of shares and stock options 1.4 6.5 0.1 0.4 4.2
Excess tax benefits (deficiencies) from stock options (1.9) (1.9) (0.2) 0.5 0.7
Net proceeds from other long-term debt - - - 0.1 -
Redemption and/or repayment of debt (1.3) (1.1) - - -
Net cash provided by (used in) financing activities (2.2) 3.5 (0.1) (85.5) 4.9
Net cash flows (49.6) (205.0) 39.4 (57.8) (74.0)
Effect of changes in exchange rates on cash 1.7 1.2 2.4 (0.5) (0.7)
Net increase (decrease) in cash & cash equivalents (47.9) (203.8) 41.8 (58.3) (74.7)

ASML - Notes to the Summary U.S. GAAP Consolidated Financial Statements

Basis of Presentation

ASML follows accounting principles generally accepted in the United States of America ("U.S. GAAP"). Further disclosures, as required under U.S. GAAP in annual reports, are not included in the summary consolidated financial statements. Unless stated otherwise, the accompanying consolidated financial statements are stated in thousands of euros ('EUR').

Principles of consolidation

The consolidated financial statements include the accounts of ASML Holding N.V. and all of its majorityowned subsidiaries. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. All intercompany profits, balances and transactions have been eliminated in the consolidation.

Use of estimates

The preparation of ASML's consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.

Recognition of revenues

ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller's price to the buyer is fixed or determinable; and collectibility is reasonably assured. At ASML, this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a "Factory Acceptance Test" in ASML's clean room facilities, effectively replicating the operating conditions that will be present on the customer's site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer. A system is shipped, and revenue recognized, only after all specifications are met and customer sign-off is received or waived. Although each system's performance is re-tested upon installation at the customer's site, ASML has never failed to successfully complete installation of a system at a customer's premises.

For arrangements containing multiple elements, the revenue relating to the undelivered elements is deferred at estimated fair value until delivery of these elements. Revenue from installation services and service contracts provided to our customers is initially deferred and is recognized when the installation is completed and, in case of service contracts, over the life of those contracts. Revenue from extended and enhanced warranties is recognized in income on a straight-line basis over the contract period. The costs of providing services under extended and enhanced warranties are recognized when they occur.

Foreign currency risk management

The Company uses the euro as its invoicing currency in order to limit the exposure to foreign currency movements. Exceptions may occur on a customer by customer basis. To the extent that invoicing is done in a currency other than the euro, the Company is exposed to foreign currency risk.

It is the Company's policy to hedge material transaction exposures, such as sales transactions and forecasted purchase transactions. The Company hedges these exposures through the use of foreign exchange options and forward contracts. The use of a mix of foreign exchange options and forward contracts is aimed at reflecting the likelihood of the transactions occurring.

It is the Company's policy to hedge material remeasurement exposures. These net exposures from certain monetary assets and liabilities in non-functional currencies are hedged with forward contracts.

As of September 27, 2009 EUR 39.8 million loss is classified as other comprehensive income, net of taxes, representing the total anticipated loss to be charged to net sales, and EUR 0.9 million loss representing the total anticipated loss to be released to cost of sales when the forecasted revenue and purchase transactions occur.

ASML – Reconciliation U.S. GAAP – IFRS 1

Net income Three months ended, Nine months ended,
Sep 28, 2008 Sep 27, 2009 Sep 28, 2008 Sep 27, 2009
(in thousands EUR)
Net income (loss) under U.S. GAAP 73,294 19,739 410,394 (201,405)
Share-based payments (see Note 1) (2,492) 1,415 (3,009) 2,311
Capitalization of development costs (see Note 2) 14,867 24,504 55,197 57,779
Reversal of write-downs (see Note 3) - 28,509 - 28,509
Income taxes (see Note 4) (3,119) (1,350) (3,081) (3,407)
Net income (loss) under IFRS 82,550 72,817 459,501 (116,213)
Shareholders' equity Sep 28, Dec 31, Mar 29, Jun 28, Sep 27,
2008 2008 2009 2009 2009
(in thousands EUR)
Shareholders' equity under U.S. GAAP 2,122,848 1,988,769 1,795,951 1,691,240 1,706,271
Share-based payments (see Note 1) (7,904) (6,537) (7,088) (4,918) (460)
Capitalization of development costs (see Note 2) 193,780 201,717 215,452 235,945 259,665
Reversal of write-downs (see Note 3) - - - - 28,509
Income taxes (see Note 4) 5,969 4,794 3,361 2,797 1,370
Shareholders' equity under IFRS 2,314,693 2,188,743 2,007,676 1,925,064 1,995,355

Notes to the reconciliation from U.S. GAAP to IFRS

Note 1 Share-based Payments

Under IFRS, ASML applies IFRS 2, "Share-based Payments" beginning from January 1, 2004. In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options and stock granted to its employees after November 7, 2002. Under IFRS, at period end a deferred tax asset is computed on the basis of the tax deduction for the share-based payments under the applicable tax law and is recognized to the extent it is probable that future taxable profit will be available against which these deductible temporary differences will be utilized. Therefore, changes in the Company's share price do affect the deferred tax asset at period-end and result in adjustments to the deferred tax asset.

As of January 1, 2006, ASML applies ASC 718 "Share-Based Payment" which requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments. ASC 718's general principle is that a deferred tax asset is established as the Company recognizes compensation costs for commercial purposes for awards that are expected to result in a tax deduction under existing tax law. Under U.S. GAAP, the deferred tax recorded on share-based compensation is computed on the basis of the expense recognized in the financial statements.

Therefore, changes in the Company's share price do not affect the deferred tax asset recorded in the Company's financial statements.

Note 2 Capitalization of development costs

Under IFRS, ASML applies IAS 38, "Intangible Assets". In accordance with IAS 38, ASML capitalizes certain development expenditures which are amortized over the expected useful life of the related product generally ranging between one and three years. Amortization starts when the developed product is ready for volume production. In 2008, we recognized an impairment charge for an amount of EUR 18.3 million.

Under U.S. GAAP, ASML applies ASC 730, "Accounting for Research and Development Costs". In accordance with ASC 730, ASML charges costs relating to research and development to operating expense as incurred.

Note 3 Reversal of write-downs

Under IFRS, ASML applies IAS 2 (revised), "Inventories". In accordance with IAS 2, reversal of a prior period write-down as a result of a subsequent increase in value of inventory should be recognized in the period in which the value increase occurs.

Under U.S. GAAP, ASML applies ASC 330 Inventory. In accordance with ASC 330 reversal of a write-down is prohibited as a write-down creates a new cost basis.

Note 4 Income taxes

Under IFRS, ASML applies IAS 12, "Income Taxes" beginning from January 1, 2005. In accordance with IAS 12 unrealized net income resulting from intercompany transactions that are eliminated from the carrying amount of assets in consolidation, give rise to a temporary difference for which deferred taxes must be recognized in consolidation. The deferred taxes are calculated based on the tax rate applicable in the purchaser's tax jurisdiction.

Under U.S. GAAP, the elimination of unrealized net income from intercompany transactions that are eliminated from the carrying amount of assets in consolidation, give rise to a temporary difference for which prepaid taxes must be recognized in consolidation. Contrary to IFRS, the prepaid taxes under U.S. GAAP are calculated based on the tax rate applicable in the seller's rather than the purchaser's tax jurisdiction.

"Safe Harbor" Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average selling price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), including the impact of credit market deterioration on consumer confidence and demand for our customers' products, competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML's Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.

  • 1 All quarterly information in this press release is unaudited.
  • 2 The calculation of diluted net income per ordinary share assumes the exercise of options issued under ASML stock option plans for periods in which exercises would have a dilutive effect, the calculation of diluted net income per ordinary share does not assume exercise of such options when such exercises would be antidilutive.